A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L. Hyer, Neil Bence, Yang Yu et al.|Nature Medicine|2018Cited by 453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Jessica Riceberg et al.|Nature Chemical Biology|2017Cited by 228
Prospective discovery of small molecule enhancers of an E3 ligase-substrate interactionK.R. Simonetta, Anjanabha Saha, Joshua P. Taygerly et al.|Nature Communications|2019Cited by 210
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Stephen Grossman et al.|Journal of Medicinal Chemistry|2021Cited by 205
Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor ProliferationXingyue He, Neil Bence|PLoS ONE|2015Cited by 60